Tuesday, May 17, 2011 5:00:07 PM
1. Bayer is doing a trial with zevalin as first line without chemo, until now they said and expected better results than using rituxan.IF is approved that it will be the new tratment in NHL, wiping out rituxan that right now has a revenue over 5 BIL a year.this not include the others trials with Zevalin
2. is been studies that shows that HDAC as belinostat has a great improvement in diabetis beside the one for T-Cell.
this is not including the outcome of Fusilev without Leucovorin and Eoquin for bladder cancer. I guess that we are sitting in a golden mine and people don't realize yet. Time will Tell
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM